Progress Toward Cardiac Xenotransplantation
Author(s) -
Richard N. Pierson,
Jay A. Fishman,
Gregory D. Lewis,
David A. D’Alessandro,
Margaret R. Connolly,
Lars Burdorf,
Joren C. Madsen,
Agnes M. Azimzadeh
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.048186
Subject(s) - xenotransplantation , medicine , translation (biology) , heart failure , intensive care medicine , transplantation , pharmacology , biology , genetics , messenger rna , gene
Consistent survival of life-supporting pig heart xenograft recipients beyond 90 days was recently reported using genetically modified pigs and a clinically applicable drug treatment regimen. If this remarkable achievement proves reproducible, published benchmarks for clinical translation of cardiac xenografts appear to be within reach. Key mechanistic insights are summarized here that informed recent pig design and therapeutic choices, which together appear likely to enable early clinical translation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom